Related Experiment Video

Updated: Apr 6, 2026

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

8.8K

Mathematical modeling reveals a critical role for cyclin D1 dynamics in phenotype switching during glioma

Xiaoqiang Sun1, Xiaoke Zheng2, Jiajun Zhang3

  • 1Research Center of Bioinformatics, Zhong-shan School of Medicine, Sun Yat-Sen University, Guangzhou 510089, China; School of Mathematical and Computational Science, Sun Yat-Sen University, Guangzhou 510000, China.

FEBS Letters
|July 20, 2015
PubMed

Insights

This study reveals a critical "one-way-switch" in cyclin D1 dynamics that controls glioma cell differentiation. Mathematical modeling and experiments offer insights for developing new anti-cancer therapies targeting glioma differentiation.

Area of Science:

  • Oncology
  • Systems Biology
  • Molecular Biology

Background:

  • Glioma differentiation therapy aims to enhance anti-glioma effects by inducing cell differentiation.
  • The precise molecular mechanisms governing glioma cell differentiation are not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms of glioma differentiation.
  • To develop an experiment-integrated mathematical model for glioma differentiation signaling pathways.
  • To evaluate drug combinations for synergistic therapeutic effects.

Main Methods:

  • Construction of an experiment-integrated mathematical model for glioma differentiation signaling.
  • Analysis of signaling pathways to identify critical control points.
  • Quantitative evaluation of drug combinations for synergistic effects.

Main Results:

  • A
  • one-way-switch
  • bifurcation in cyclin D1 dynamics was identified as crucial for glioma cell phenotypic transition.
  • The mathematical model accurately reflects experimental observations of glioma differentiation.
  • Synergistic effects of drug combinations were quantitatively assessed.

Conclusions:

  • Cyclin D1 dynamics play a pivotal role in controlling glioma cell differentiation.
  • The developed model provides a framework for understanding glioma differentiation mechanisms.
  • Findings have implications for designing novel therapeutic strategies against glioma.
Keywords:
Cyclin D1Glioma differentiationMathematical modelingPhenotype switching

More Related Videos

A Human Glioblastoma Organotypic Slice Culture Model for Study of Tumor Cell Migration and Patient-specific Effects of Anti-Invasive Drugs08:35

A Human Glioblastoma Organotypic Slice Culture Model for Study of Tumor Cell Migration and Patient-specific Effects of Anti-Invasive Drugs

Published on: July 20, 2017

13.8K
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

8.4K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.1K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
137.2K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.8K
Cells Coordinate Growth and Proliferation02:36

Cells Coordinate Growth and Proliferation

Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
5.3K